Latest Period
Q1 2026
Security Snapshot
Jazz Pharmaceuticals plc - Common Stock (JAZZ) Institutional Ownership
CUSIP: G50871105
13F Institutional Holders and Ownership History from Q1 2014 to Q1 2026
Institutions Reporting
568
Shares (Excl. Options)
65,027,150
Price
$189.05
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock
- Symbol
- JAZZ on Nasdaq
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 65,027,150
- Total 13F value
- $12,280,300,798
- Portfolio coverage rank
- 0.01%
- Share change
- +3,497,926
- Value change
- +$701,842,844
- Number of holders
- 568
- Shares outstanding
- 61,577,817
- SEC-reported price per share
- $237.56
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
2 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- JAZZ - Jazz Pharmaceuticals plc - Common Stock is tracked under CUSIP G50871105.
- 568 institutions reported positions in Q1 2026.
- 1 significant owner is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 573 to 568 between Q4 2025 and Q1 2026.
- SEC-reported value moved from $10,480,482,425 to $12,280,300,798.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 568 institutions filings for Q1 2026.
Security key
G50871105
Latest holder period
Q1 2026
13F holders
568
13D/G owners
1
CIK / CUSIP context first
Open Q1 2026 holders
JAZZ full holder history
Jazz Pharmaceuticals plc SEC filings
Jazz Pharmaceuticals plc company facts
Jazz Pharmaceuticals plc insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP G50871105:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
1
Security
JAZZ
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | 5% | $633,056,418 | 3,103,522 | Vanguard Capital Management | 31 Mar 2026 |
As of 31 Mar 2026, 568 institutional investors reported holding 65,027,150 shares of Jazz Pharmaceuticals plc - Common Stock (JAZZ). This represents 106% of the company’s total 61,577,817 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
70%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| BlackRock, Inc. | 9.1% | 5,591,700 | +2.6% | 0.02% | $1,057,110,973 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 4.8% | 2,983,242 | 0% | 0.03% | $563,981,900 |
| Capital World Investors | 4.3% | 2,673,376 | +0.25% | 0.07% | $505,401,733 |
| VANGUARD CAPITAL MANAGEMENT LLC | 4.3% | 2,648,333 | 0% | 0.01% | $500,667,354 |
| LSV ASSET MANAGEMENT | 3.9% | 2,386,840 | -2.8% | 0.97% | $451,232,000 |
| FMR LLC | 3.7% | 2,275,762 | +184% | 0.02% | $430,232,708 |
| FRANKLIN RESOURCES INC | 3.2% | 1,958,940 | +7.7% | 0.09% | $370,337,696 |
| DIMENSIONAL FUND ADVISORS LP | 3.1% | 1,895,215 | -28% | 0.07% | $358,264,016 |
| STATE STREET CORP | 3.1% | 1,891,646 | +2.9% | 0.01% | $357,615,676 |
| EcoR1 Capital, LLC | 2.8% | 1,706,469 | 0% | 14% | $322,607,964 |
| Bank of New York Mellon Corp | 2.7% | 1,679,371 | +45% | 0.06% | $317,485,045 |
| FULLER & THALER ASSET MANAGEMENT, INC. | 2.7% | 1,676,142 | -0.06% | 1.1% | $316,874,674 |
| AMERIPRISE FINANCIAL INC | 2.6% | 1,608,476 | +5.7% | 0.07% | $304,082,388 |
| AQR CAPITAL MANAGEMENT LLC | 2.2% | 1,338,458 | +53% | 0.11% | $249,863,354 |
| MILLENNIUM MANAGEMENT LLC | 2.1% | 1,262,511 | +5% | 0.18% | $238,677,705 |
| CITADEL ADVISORS LLC | 2% | 1,259,444 | +305% | 0.17% | $238,097,888 |
| GEODE CAPITAL MANAGEMENT, LLC | 2% | 1,237,617 | +3.4% | 0.01% | $234,026,208 |
| JPMORGAN CHASE & CO | 2% | 1,204,353 | +15% | 0.01% | $220,577,545 |
| BANK OF AMERICA CORP /DE/ | 1.6% | 1,014,800 | +11% | 0.01% | $191,847,960 |
| Swedbank AB | 1.6% | 992,108 | -10% | 0.2% | $187,558,018 |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 1.4% | 885,201 | +25% | 0.19% | $167,347,248 |
| RENAISSANCE TECHNOLOGIES LLC | 1.3% | 819,374 | -2.1% | 0.24% | $154,902,655 |
| Holocene Advisors, LP | 1.2% | 733,905 | +24% | 0.34% | $138,744,740 |
| MORGAN STANLEY | 1.1% | 698,738 | +9.3% | 0.01% | $132,096,707 |
| Allianz Asset Management GmbH | 0.99% | 610,297 | +1.9% | 0.13% | $115,376,648 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
49
Latest
Q1 2026
Rows shown
1-25 of 49
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 65,027,150 | $12,280,300,798 | +$701,842,844 | $189.05 | 568 |
| 2025 Q4 | 61,702,488 | $10,480,482,425 | +$192,018,597 | $170.00 | 573 |
| 2025 Q3 | 60,646,127 | $7,990,617,646 | -$150,715,669 | $131.80 | 498 |
| 2025 Q2 | 61,824,515 | $6,561,677,298 | +$172,218,482 | $106.12 | 497 |
| 2025 Q1 | 59,973,813 | $7,442,798,617 | +$115,230,167 | $124.15 | 545 |
| 2024 Q4 | 59,002,163 | $7,265,494,814 | +$147,830,867 | $123.15 | 502 |
| 2024 Q3 | 57,597,455 | $6,415,433,594 | +$58,344,093 | $111.41 | 469 |
| 2024 Q2 | 57,463,700 | $6,133,341,626 | -$38,433,148 | $106.73 | 451 |
| 2024 Q1 | 57,711,183 | $6,947,614,300 | +$89,820,559 | $120.42 | 475 |
| 2023 Q4 | 57,060,984 | $7,017,863,210 | -$56,981,989 | $123.00 | 491 |
| 2023 Q3 | 56,530,271 | $7,318,098,320 | -$17,277,114 | $129.44 | 482 |
| 2023 Q2 | 56,728,151 | $7,039,068,770 | -$22,114,573 | $123.97 | 465 |
| 2023 Q1 | 56,681,319 | $8,292,329,555 | +$108,158,178 | $146.33 | 462 |
| 2022 Q4 | 56,178,304 | $8,948,272,058 | -$100,056,709 | $159.31 | 475 |
| 2022 Q3 | 56,928,016 | $7,590,657,250 | -$96,379,512 | $133.29 | 443 |
| 2022 Q2 | 57,260,089 | $8,932,716,610 | +$138,065,500 | $156.01 | 448 |
| 2022 Q1 | 56,748,008 | $8,837,789,303 | -$111,358,494 | $155.67 | 437 |
| 2021 Q4 | 57,664,502 | $7,350,056,970 | +$21,422,030 | $127.40 | 422 |
| 2021 Q3 | 56,879,540 | $7,407,482,783 | -$119,725,201 | $130.21 | 422 |
| 2021 Q2 | 57,178,368 | $10,156,395,395 | +$780,868,772 | $177.64 | 481 |
| 2021 Q1 | 53,127,709 | $8,729,942,643 | +$29,540,811 | $164.37 | 435 |
| 2020 Q4 | 52,654,654 | $8,685,222,791 | -$294,935,573 | $165.05 | 428 |
| 2020 Q3 | 54,543,371 | $7,767,396,418 | +$369,110,226 | $142.59 | 382 |
| 2020 Q2 | 52,094,206 | $5,741,576,836 | +$270,141,092 | $110.34 | 376 |
| 2020 Q1 | 49,800,360 | $4,968,187,513 | -$262,951,825 | $99.74 | 397 |